Literature DB >> 10052953

Identification of residues essential for human paraoxonase (PON1) arylesterase/organophosphatase activities.

D Josse1, W Xie, F Renault, D Rochu, L M Schopfer, P Masson, O Lockridge.   

Abstract

Human serum paraoxonase (PON1) is a calcium-dependent organophosphatase. To identify residues essential for PON1 activity, we adopted complementary approaches based on chemical modification and site-directed mutagenesis. To detect 45Ca2+ binding to native and chemically modified PON1, we performed nondenaturating gel electrophoresis. The environment of calcium-binding sites was probed using the Ca2+ analogue, terbium. Tb3+ binds to calcium-binding sites as shown by displacement of 45Ca2+ by Tb3+. Binding of Tb3+ is accompanied by a complete loss of enzyme activity. PON1 chemical modification with the Trp-selective reagent, N-bromosuccinimide, and the Asp/Glu-selective, dicyclohexylcarbodiimide, established that Trp and Asp/Glu residues are components of the PON1 active center and calcium-binding sites. Additional evidence for the presence of a Trp residue in the PON1 calcium-binding sites was a characteristic fluorescence emission at 545 nm from the PON1-Tb3+ complex and abolishment of that fluorescence upon modification by N-bromosuccinimide. The importance of aromatic/hydrophobic character of the residue 280 was demonstrated by site-directed mutagenesis: the W280F mutant was fully active while the W280A and W280L mutants had markedly reduced activity. Twelve amino acids among conserved His and Asp/Glu residues were found essential for PON1 arylesterase and organophosphatase activities: H114, H133, H154, H242, H284, D53, D168, D182, D268, D278, E52, and E194. Finally, the cysteines constituting the PON1 disulfide bond (C41 and C352) were essential, but the glycan chains linked to Asn 252 and 323 were not essential for PON1 secretion and activity.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10052953     DOI: 10.1021/bi982281h

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  20 in total

1.  One enzyme, two functions: PON2 prevents mitochondrial superoxide formation and apoptosis independent from its lactonase activity.

Authors:  Sebastian Altenhöfer; Ines Witte; John F Teiber; Petra Wilgenbus; Andrea Pautz; Huige Li; Andreas Daiber; Heidrun Witan; Albrecht M Clement; Ulrich Förstermann; Sven Horke
Journal:  J Biol Chem       Date:  2010-06-08       Impact factor: 5.157

2.  Directed evolution of mammalian paraoxonases PON1 and PON3 for bacterial expression and catalytic specialization.

Authors:  Amir Aharoni; Leonid Gaidukov; Shai Yagur; Lilly Toker; Israel Silman; Dan S Tawfik
Journal:  Proc Natl Acad Sci U S A       Date:  2003-12-26       Impact factor: 11.205

Review 3.  The human paraoxonase gene cluster as a target in the treatment of atherosclerosis.

Authors:  Zhi-Gang She; Hou-Zao Chen; Yunfei Yan; Hongliang Li; De-Pei Liu
Journal:  Antioxid Redox Signal       Date:  2011-10-18       Impact factor: 8.401

4.  Paraoxonase gene mutations in amyotrophic lateral sclerosis.

Authors:  Nicola Ticozzi; Ashley Lyn LeClerc; Pamela J Keagle; Jonathan D Glass; Anne-Marie Wills; Marka van Blitterswijk; Daryl A Bosco; Ildefonso Rodriguez-Leyva; Cinzia Gellera; Antonia Ratti; Franco Taroni; Diane McKenna-Yasek; Peter C Sapp; Vincenzo Silani; Clement E Furlong; Robert H Brown; John E Landers
Journal:  Ann Neurol       Date:  2010-07       Impact factor: 10.422

5.  Stereoselective hydrolysis of organophosphate nerve agents by the bacterial phosphotriesterase.

Authors:  Ping-Chuan Tsai; Andrew Bigley; Yingchun Li; Eman Ghanem; C Linn Cadieux; Shane A Kasten; Tony E Reeves; Douglas M Cerasoli; Frank M Raushel
Journal:  Biochemistry       Date:  2010-09-21       Impact factor: 3.162

6.  Protective action of CLA against oxidative inactivation of paraoxonase 1, an antioxidant enzyme.

Authors:  Nguyen-Duy Su; Xi-Wen Liu; Mee Ree Kim; Tae-Sook Jeong; Dai-Eun Sok
Journal:  Lipids       Date:  2003-06       Impact factor: 1.880

7.  Drosophila are protected from Pseudomonas aeruginosa lethality by transgenic expression of paraoxonase-1.

Authors:  David A Stoltz; Egon A Ozer; Peter J Taft; Marilyn Barry; Lei Liu; Peter J Kiss; Thomas O Moninger; Matthew R Parsek; Joseph Zabner
Journal:  J Clin Invest       Date:  2008-09       Impact factor: 14.808

Review 8.  Pharmacogenetics of paraoxonases: a brief review.

Authors:  D I Draganov; B N La Du
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2003-10-25       Impact factor: 3.000

9.  Beneficial effect of oleoylated lipids on paraoxonase 1: protection against oxidative inactivation and stabilization.

Authors:  Su Duy Nguyen; Dai-Eun Sok
Journal:  Biochem J       Date:  2003-10-15       Impact factor: 3.857

10.  A common mutation in paraoxonase-2 results in impaired lactonase activity.

Authors:  David A Stoltz; Egon A Ozer; Thomas J Recker; Miriam Estin; Xia Yang; Diana M Shih; Aldons J Lusis; Joseph Zabner
Journal:  J Biol Chem       Date:  2009-12-18       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.